Ocugen: FDA declines to issue EUA for COVAXIN in pediatric population (ages 2-18)

Ocugen, Inc.

CFO Sanjay Subramanian resigns effective March 18, 2022; no disagreement with company.
Board appoints Jessica Crespo (VP Corporate Controller) as Chief Accounting Officer and SVP Finance.
FDA declined to issue Emergency Use Authorization for COVAXIN for ages 2-18.
Ocugen intends to continue working with FDA to evaluate regulatory pathway for pediatric use.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Sanjay S. Subramanian

Chief Financial Officer

OCGN · Ocugen, Inc.

Effective: 2022-03-18
Successor: Jessica Crespo
Filed: March 4, 2022, 6:59 PM ET

On March 2, 2022, Sanjay S. Subramanian, Chief Financial Officer and Head of Corporate Development of Ocugen, Inc. (the “Company”), tendered his resignation to the Company, effective as of March 18, 2022 (the “Effective Date”), in order to pursue new opportunities.

Role change

Jessica Crespo

Chief Accounting Officer and Senior Vice President, Finance

OCGN · Ocugen, Inc.

Effective: 2022-03-18
Filed: March 4, 2022, 6:59 PM ET

On March 4, 2022, the Board appointed Jessica Crespo, the Company’s Vice President, Corporate Controller & Treasurer, to Chief Accounting Officer and Senior Vice President, Finance, effective as of the Effective Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sanjay S. Subramanian resigned as Chief Financial Officer at Ocugen, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On March 2, 2022, Sanjay S. Subramanian, Chief Financial Officer and Head of Corporate Development of Ocugen, Inc. (the “Company”), tendered his resignation to the Company, effective as of March 18, 2022 (the “Effective Date”), in order to pursue new opportunities.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jessica Crespo was appointed as Chief Accounting Officer and Senior Vice President, Finance at Ocugen, Inc..

Action: appointed
Role: Chief Accounting Officer and Senior Vice President, Finance

Exact text from the filing

On March 4, 2022, the Board appointed Jessica Crespo, the Company’s Vice President, Corporate Controller & Treasurer, to Chief Accounting Officer and Senior Vice President, Finance, effective as of the Effective Date.

View on SEC.gov

Ocugen, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-030623

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.